Procyon's average Accounts Payable for the
three
months ended in Jun. 2024 was $0.18 Mil. Procyon's Cost of Goods Sold for the
three
months ended in Jun. 2024 was $0.31 Mil.
Hence, Procyon's Days Payable for the
three
months ended in Jun. 2024 was 54.66.
The historical rank and industry rank for Procyon's Days Payable or its related term are showing as below:
PCYN's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.98 * Ranked among companies with meaningful Days Payable only.
Procyon's Days Payable
declined
from Jun. 2023 (65.94) to Jun. 2024 (54.66).
It may suggest that Procyonaccelerated paying its suppliers.
Procyon Days Payable Related Terms
Procyon Days Payable Historical Data
* Premium members only.
The historical data trend for Procyon's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Procyon's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procyon Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Procyon's Days Payable distribution charts can be found below:
* The bar in red indicates where Procyon's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Procyon's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procyon (PCYN) has a Days Payable of 54.66 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Procyon and its competitors.
Is Procyon's Days Payable too high?
Procyon's current Days Payable is 54.66. The Drug Manufacturers industry median Days Payable is 90.98. Procyon's value of 54.66 is 39.9% below this industry median. Overall, Procyon has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Procyon's Days Payable compare to KAYS and YCBD?
Procyon's Days Payable of 54.66 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.98. Procyon's value of 54.66 is 39.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procyon's current Days Payable of 54.66 is 39.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Procyon and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procyon's current Days Payable is 54.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procyon stock overvalued right now?
Procyon (PCYN) has a current Days Payable of 54.66. The current Days Payable is 54.66 and 39.9% below the Drug Manufacturers industry median of 90.98. Procyon's overall GF Score™ is 48/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Procyon (PCYN), the current Days Payable is 54.66 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
48GF Score
Get the complete analysis for PCYN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PCYN has been successfully added to your 
